Literature DB >> 22321465

Brain imaging and hepatic encephalopathy.

Mark J W McPhail1, Neeral R Patel, Simon D Taylor-Robinson.   

Abstract

Novel imaging techniques allow the investigation of structural and functional neuropathology of hepatic encephalopathy in greater detail, but limited techniques are applicable to the clinic. Computed tomography and magnetic resonance imaging (MRI) can rule out other diagnoses and, in MRI, give diagnostic features in widely available sequences. An internationally accepted diagnostic framework that includes an objective imaging test to replace or augment psychometry remains elusive. Quantitative MRI is likely to be the best candidate to become this test. The utility of MR and nuclear medical techniques to the clinic and results from recent research are described in this article.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22321465     DOI: 10.1016/j.cld.2011.12.001

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  15 in total

1.  Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted MR imaging and proton MR spectroscopy of the brain.

Authors:  Ahmed Abdel Khalek Abdel Razek; Ahmed Abdalla; Amany Ezzat; Ahmed Megahed; Tarek Barakat
Journal:  Neuroradiology       Date:  2014-07-25       Impact factor: 2.804

Review 2.  Brain edema: a valid endpoint for measuring hepatic encephalopathy?

Authors:  Chantal Bémeur; Cristina Cudalbu; Gitte Dam; Alexander S Thrane; Arthur J L Cooper; Christopher F Rose
Journal:  Metab Brain Dis       Date:  2016-06-07       Impact factor: 3.584

Review 3.  Resting-state functional magnetic resonance imaging in hepatic encephalopathy: current status and perspectives.

Authors:  Long Jiang Zhang; Shengyong Wu; Jiaqian Ren; Guang Ming Lu
Journal:  Metab Brain Dis       Date:  2014-02-22       Impact factor: 3.584

Review 4.  Multimodal MR imaging in hepatic encephalopathy: state of the art.

Authors:  Xiao Dong Zhang; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2018-01-26       Impact factor: 3.584

Review 5.  Hepatic encephalopathy.

Authors:  Dieter Häussinger; Radha K Dhiman; Vicente Felipo; Boris Görg; Rajiv Jalan; Gerald Kircheis; Manuela Merli; Sara Montagnese; Manuel Romero-Gomez; Alfons Schnitzler; Simon D Taylor-Robinson; Hendrik Vilstrup
Journal:  Nat Rev Dis Primers       Date:  2022-06-23       Impact factor: 65.038

6.  Spectrum of Neuroimaging Abnormalities in Brain in Patients of Acute-on-Chronic Liver Failure.

Authors:  Shekhar S Jadaun; Sanchit Sharma; Kumble S Madhusudhan; Raju Sharma; Baibaswata Nayak; Saurabh Kedia; Vishwajeet Singh; Deepak Gunjan; Subrat K Acharya; Anoop Saraya
Journal:  J Clin Exp Hepatol       Date:  2021-08-21

7.  1H and 31P magnetic resonance spectroscopy in a rat model of chronic hepatic encephalopathy: in vivo longitudinal measurements of brain energy metabolism.

Authors:  Veronika Rackayova; Olivier Braissant; Valérie A McLin; Corina Berset; Bernard Lanz; Cristina Cudalbu
Journal:  Metab Brain Dis       Date:  2015-08-09       Impact factor: 3.584

8.  Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis.

Authors:  Jasmohan S Bajaj; Vishwadeep Ahluwalia; James B Wade; Arun J Sanyal; Melanie B White; Nicole A Noble; Pamela Monteith; Michael Fuchs; Richard K Sterling; Velimir Luketic; Iliana Bouneva; Richard T Stravitz; Puneet Puri; Kenneth A Kraft; Hochong Gilles; Douglas M Heuman
Journal:  J Hepatol       Date:  2012-08-11       Impact factor: 25.083

Review 9.  Multimodality magnetic resonance imaging in hepatic encephalopathy: an update.

Authors:  Xiao-Dong Zhang; Long-Jiang Zhang; Sheng-Yong Wu; Guang-Ming Lu
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

10.  Altered effective connectivity network of the basal ganglia in low-grade hepatic encephalopathy: a resting-state fMRI study with Granger causality analysis.

Authors:  Rongfeng Qi; Long Jiang Zhang; Jianhui Zhong; Zhiqiang Zhang; Ling Ni; Qing Jiao; Wei Liao; Gang Zheng; Guangming Lu
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.